60
Days Left
Lead Plaintiff Deadline
Nov 30, 2026
Please Upload related files below
Fill in below.
Tell us the stocks you own using SnapTrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. SnapTrade only shares the tickers you own and your transaction history, not your account numbers. Using SnapTrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery - link your brokerage account with SnapTrade.
The filed complaint alleges that Endava plc made materially false and/or misleading statements and/or failed to disclose that: (1) the accounting treatment for certain customer and supplier agreements and related matters required additional review; (2) as a result of the foregoing, the Company would delay the release of its fourth quarter and full year 2026 financial results; (3) there was reason to doubt the effectiveness of the Company’s internal controls and procedures; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Investors who purchased or otherwise acquired Endava plc securities within the class period described above and suffered losses may be eligible.
If you suffered a loss in Endava plc during the relevant time frame or pursuant to the relevant offering(s), you have until November 30, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
● The Allegation: The complaint alleges that Endava made materially false and misleading statements by failing to disclose that the accounting treatment for certain customer and supplier agreements required additional review, that this would delay the release of its fourth quarter and full year 2026 financial results, and that there was reason to doubt the effectiveness of the Company's internal controls and procedures.
● The Stock Drop: On September 22, 2026, Endava's American Depositary Shares fell $0.68 per share (24.37%) to close at $2.11 per share, after the Company announced that its Chief Financial Officer had been placed on administrative leave amid an internal investigation into the accounting treatment of certain customer and supplier agreements.
● Class Period & Defendants: The class period runs from September 4, 2025 through September 21, 2026, inclusive. The named defendants are Endava plc, John Cotterell (Chief Executive Officer), and Mark Thurston (Chief Financial Officer).
● Lead Plaintiff Deadline: November 30, 2026. Investors who wish to seek appointment as lead plaintiff must apply by the deadline.
|
Endava Class Action Summary |
|
|
Company |
Endava plc (NYSE: DAVA) |
|
Lead Plaintiff Deadline |
November 30, 2026 |
|
Class Period |
September 4, 2025 – September 21, 2026 |
|
Stock Drop |
September 22, 2026 – DAVA fell $0.68 (24.37%) to $2.11 |
A securities class action lawsuit has been filed against Endava plc (NYSE: DAVA). The case is on behalf of persons and entities who purchased or otherwise acquired Endava securities during the class period and were allegedly damaged thereby. The class period runs from September 4, 2025 through September 21, 2026.
The complaint alleges that Endava made materially false and misleading statements about its business and financial controls. It claims the Company hid that the accounting for certain customer and supplier agreements needed more review. It also claims the Company would delay its fourth quarter and full year 2026 results, and that its internal controls were in doubt.
On September 21, 2026, Endava announced that its Chief Financial Officer had been placed on administrative leave amid an accounting investigation. The stock then fell $0.68 per share, or 24.37%, to $2.11 per share. Investors say they suffered losses as a result.
Endava plc provides technology services in North America, Europe, the United Kingdom, and internationally. The Company offers digital product acceleration services and digital engineering services, and its American Depositary Shares trade on the New York Stock Exchange under the ticker DAVA.
September 4, 2025–September 21, 2026
Investors who purchased or acquired Endava plc (DAVA) securities during the Class Period may be eligible to seek recovery under the federal securities laws.
The complaint centers on Endava's public statements about its financial results and internal controls during the class period. According to the lawsuit, the Company repeatedly reported financial results and reassured investors about the strength of its business, its AI-native strategy, and its financial reporting practices, while allegedly concealing material problems with the accounting treatment of certain customer and supplier agreements.
The class period begins on September 4, 2025, when Endava issued a press release announcing financial results for the fourth quarter and year ended June 30, 2025, and filed its annual report on Form 20-F. The complaint alleges that the annual report affirmed the reported results and stated that the Company's internal control over financial reporting was effective as of June 30, 2025, and that there were no changes materially affecting those controls. The filing also described the Company's revenue recognition methodology under IFRS 15 and warned of risks that could arise if the Company failed to maintain effective internal controls.
The complaint alleges these and later statements, including quarterly results announced on November 11, 2025, February 19, 2026, and May 21, 2026, were materially false and misleading. According to the lawsuit, defendants failed to disclose that the accounting treatment for certain customer and supplier agreements and related matters required additional review, that the Company would delay the release of its fourth quarter and full year 2026 financial results, and that there was reason to doubt the effectiveness of the Company's internal controls and procedures.
The complaint alleges that, as a result, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and lacked a reasonable basis. It claims the Individual Defendants, given their senior positions and access to material non-public information, knew or recklessly disregarded that these adverse facts were being concealed from the public.
After the market closed on September 21, 2026, Endava announced that its Chief Financial Officer, Mark Thurston, had been placed on administrative leave upon the recommendation of the Audit Committee of the Board. The Company disclosed that his leave was pending the conclusion of an ongoing investigation being conducted by independent outside counsel for the Audit Committee, which was initiated in response to concerns about the Company's accounting treatment of certain customer and supplier agreements and related matters.
In the same announcement, Endava said that Conor McShane of AlixPartners LLP had been appointed as Interim Chief Financial Officer, effective immediately. According to the complaint, the September 21 disclosure concerned an ongoing investigation into the Company's accounting treatment of certain customer and supplier agreements and related matters, initiated in response to concerns raised by the Company's outside auditors.
The market reacted sharply to the disclosure. On September 22, 2026, the price of Endava's American Depositary Shares fell $0.68 per share, or 24.37%, to close at $2.11 per share, on unusually heavy trading volume. The complaint notes that the Company's share price had closed at a class period high of $10.18 per share on September 5, 2025, underscoring the extent of the decline over the class period.
● Lead Plaintiff Deadline: November 30, 2026
● After the lead plaintiff deadline, the Court will consider any lead plaintiff motions.
● Defendants may file a motion to dismiss.
● If the case proceeds, the Court may later consider class certification.
Disclaimer: This shareholder alert is for informational purposes only and does not constitute legal advice. Consult a qualified attorney for personalized guidance. Prior results do not guarantee similar outcomes.
Class Period
September 4, 2025 - September 21, 2026
Next Steps
● Lead Plaintiff Deadline: November 30, 2026
● After the lead plaintiff deadline, the Court will consider any lead plaintiff motions.
● Defendants may file a motion to dismiss.
● If the case proceeds, the Court may later consider class certification.
Disclaimer: This shareholder alert is for informational purposes only and does not constitute legal advice. Consult a qualified attorney for personalized guidance. Prior results do not guarantee similar outcomes
The lawsuit alleges that Endava plc (NYSE: DAVA) made materially false and misleading statements between September 4, 2025 and September 21, 2026. According to the complaint, defendants failed to disclose that the accounting treatment for certain customer and supplier agreements required additional review, that the Company would delay the release of its fourth quarter and full year 2026 financial results, and that there was reason to doubt the effectiveness of the Company's internal controls. The complaint claims these omissions made defendants' positive statements about the business materially misleading and lacking a reasonable basis.
The complaint names Endava plc as a defendant, along with two individual defendants. According to the complaint, John Cotterell served as the Company's Chief Executive Officer at all relevant times, and Mark Thurston served as the Company's Chief Financial Officer at all relevant times. The complaint alleges that the Individual Defendants, because of their senior positions and access to material non-public information, had the power to control the contents of the Company's reports, press releases, and public statements, and are liable for the alleged false statements.
According to the complaint, Endava announced after the market closed on September 21, 2026 that its Chief Financial Officer had been placed on administrative leave amid an ongoing investigation into the Company's accounting treatment of certain customer and supplier agreements and related matters. The investigation was initiated in response to concerns raised by the Company's outside auditors. On this news, the price of Endava's American Depositary Shares fell $0.68 per share, or 24.37%, to close at $2.11 per share on September 22, 2026, on unusually heavy trading volume.
The class period runs from September 4, 2025 through September 21, 2026, inclusive. According to the complaint, this period begins with Endava's announcement of its fourth quarter and full year 2025 results and the filing of its annual report on Form 20-F, and ends with the September 21, 2026 disclosure that the Chief Financial Officer was placed on administrative leave amid an accounting investigation. Investors who purchased or acquired Endava securities during this period may be eligible to seek recovery under the federal securities laws.
A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Investors who purchased or acquired Endava plc (DAVA) securities during the class period may seek appointment as lead plaintiff. The role is typically filled by an investor with a significant financial interest in the outcome. Investors who wish to seek appointment as lead plaintiff must apply by the deadline. The lead plaintiff deadline is November 30, 2026.
According to the complaint, Endava failed to disclose that the accounting treatment for certain customer and supplier agreements and related matters required additional review, and that this would cause the Company to delay the release of its fourth quarter and full year 2026 financial results. The complaint also alleges that there was reason to doubt the effectiveness of the Company's internal controls and procedures, despite the Company stating in its annual report that its internal control over financial reporting was effective as of June 30, 2025.
The lead plaintiff deadline is November 30, 2026.
The lawsuit alleges Endava plc (NYSE: DAVA) made materially false and misleading statements and failed to disclose that the accounting for certain customer and supplier agreements needed additional review and that its internal controls were in doubt.
Endava disclosed on September 21, 2026 that its Chief Financial Officer was placed on leave amid an accounting investigation. The stock fell $0.68 per share, or 24.37%, to close at $2.11 per share on September 22, 2026.
The class period runs from September 4, 2025 through September 21, 2026, inclusive, covering investors who purchased or acquired Endava securities during that time.
The complaint names Endava plc, Chief Executive Officer John Cotterell, and Chief Financial Officer Mark Thurston as defendants.
The lead plaintiff deadline is November 30, 2026.
Deadline
Nov 30, 2026